Karuna Therapeutics, Inc.

CITADEL ADVISORS LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

158,012

Value ($000)

50,012

Weight

0.1%

2019 Q4 - 2023 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	50,012	0.1%	158,012	12/31/2023
2023 Q3	11/14/2023	32,059	0.0%	189,597	9/30/2023
2023 Q2	8/14/2023	20,543	0.0%	94,734	6/30/2023
2022 Q4	2/14/2023	5,535	0.0%	28,168	12/31/2022
2022 Q3	11/14/2022	18,858	0.0%	83,841	9/30/2022
2022 Q2	8/15/2022	2,482	0.0%	19,619	6/30/2022
2022 Q1	5/16/2022	2,116	0.0%	16,688	3/31/2022
2021 Q4	2/14/2022	966	0.0%	7,375	12/31/2021
2021 Q3	11/15/2021	1,400	0.0%	11,441	9/30/2021
2021 Q2	8/16/2021	207	0.0%	1,812	6/30/2021
2020 Q4	2/16/2021	2,666	0.0%	26,236	12/31/2020
2020 Q3	11/16/2020	696	0.0%	9,010	9/30/2020
2020 Q2	8/14/2020	826	0.0%	7,415	6/30/2020
2020 Q1	5/15/2020	6,030	0.0%	83,751	3/31/2020
2019 Q4	2/14/2020	351	0.0%	4,652	12/31/2019